Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 36669140

Randomized Phase III Trial of Ganitumab With Interval-Compressed Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma: A Report From the Children's Oncology Group.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2023 Apr 10
First author
DuBois SG

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Transl Pediatr. 2023 Oct 30;12(10):1916-1919. doi: 10.21037/tp-23-388.
    note
    Source null
    related pmid
    37969125
    relationship
    Comment in

Authors and identifiers

  1. name
    DuBois SG
    type
    Author
  2. name
    Krailo MD
    type
    Author
  3. name
    Glade-Bender J
    type
    Author
  4. name
    Buxton A
    type
    Author
  5. name
    Laack N
    type
    Author
  6. name
    Randall RL
    type
    Author
  7. name
    Chen HX
    type
    Author
  8. name
    Seibel NL
    type
    Author
  9. name
    Boron M
    type
    Author
  10. name
    Terezakis S
    type
    Author
  11. name
    Hill-Kayser C
    type
    Author
  12. name
    Hayes A
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    DuBois SG
    type
    Author
  2. name
    Krailo MD
    type
    Author
  3. name
    Glade-Bender J
    type
    Author
  4. name
    Buxton A
    type
    Author
  5. name
    Laack N
    type
    Author
  6. name
    Randall RL
    type
    Author
  7. name
    Chen HX
    type
    Author
  8. name
    Seibel NL
    type
    Author
  9. name
    Boron M
    type
    Author
  10. name
    Terezakis S
    type
    Author
  11. name
    Hill-Kayser C
    type
    Author
  12. name
    Hayes A
    type
    Author
bibliography ids
  1. nci-bib-0bbd11c197bec124c92cf4e0
book metadata
content sha256
e3e240759f7b1e867944def38c74b27c5b1ba981c68a9338eb52be35430b81ab
document type
citation
dois
  1. 10.1200/JCO.22.01815
electronic publication date
display
2023 Jan 20
precision
day
year
2023
evidence scope
bibliographic_metadata_only
id
pubmed:36669140
immutable id
pubmed:36669140@e3e240759f7b1e867944def38c74b27c5b1ba981c68a9338eb52be35430b81ab
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
11
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
2098-2107
volume
41
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Transl Pediatr. 2023 Oct 30;12(10):1916-1919. doi: 10.21037/tp-23-388.
    note
    Source null
    related pmid
    37969125
    relationship
    Comment in
outcomes validated
false
pmid
36669140
provenance
batch id
d370e99271168e8a8a13
provider
NCBI PubMed ESummary
record sha256
e921751b208540da5bcba6a6ca23211ea2543ea79310e5bbcda59c871c4b5464
response sha256
f65ace3ceb1efa86f3fbab8e01ce265243e7c6b7f13c5f71c357c1f219ad79c4
retrieved at
2026-09-09T23:48:13.005737+00:00
publication date
display
2023 Apr 10
precision
day
year
2023
publication types
  1. Randomized Controlled Trial
  2. Clinical Trial, Phase III
  3. Journal Article
  4. Research Support, N.I.H., Extramural
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/36669140/
title
Randomized Phase III Trial of Ganitumab With Interval-Compressed Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma: A Report From the Children's Oncology Group.

Preserved source evidence · Not medical advice